Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

NCT ID: NCT06858839

Last Updated: 2025-10-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

3853 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-12

Study Completion Date

2027-04-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Maridebart Cafraglutide High Dose

Participants will receive maridebart cafraglutide high dose subcutaneously (SC) for 72 weeks.

Group Type EXPERIMENTAL

Maridebart Cafraglutide

Intervention Type DRUG

Maridebart cafraglutide will be administered SC.

Maridebart Cafraglutide Medium Dose

Participants will receive maridebart cafraglutide medium dose SC for 72 weeks.

Group Type EXPERIMENTAL

Maridebart Cafraglutide

Intervention Type DRUG

Maridebart cafraglutide will be administered SC.

Maridebart Cafraglutide Low Dose

Participants will receive maridebart cafraglutide low dose SC for 72 weeks.

Group Type EXPERIMENTAL

Maridebart Cafraglutide

Intervention Type DRUG

Maridebart cafraglutide will be administered SC.

Placebo

Participants will receive placebo SC for 72 weeks.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo will be administered SC.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Maridebart Cafraglutide

Maridebart cafraglutide will be administered SC.

Intervention Type DRUG

Placebo

Placebo will be administered SC.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

AMG 133 MariTide

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years.
* Body mass index ≥ 30 kg/m2 or ≥27 kg/m² to \< 30 kg/m2 with at least 1 of the following weight-related comorbidities: hypertension, dyslipidemia, history of obstructive sleep apnea, history of cardiovascular disease, history of metabolic dysfunction-associated steatotic liver disease (MASLD) or Metabolic Dysfunction-Associated Steatohepatitis (MASH).
* History of at least 1 self-reported unsuccessful attempt at weight loss by diet and exercise.

Exclusion Criteria

* Type 1 or Typ2 diabetes mellitus.
* Obesity induced by other endocrinologic disorders.
* Self-reported change in body weight \> 5 kg within 90 days before screening.
* Family (first-degree relative\[s\]) or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2.
* History of chronic pancreatitis or history of acute pancreatitis within 180 days before screening.
* History of unstable major depressive disorder (MDD) or other severe psychiatric disorder within 2 years before screening.
* Lifetime history of suicide attempt.
Minimum Eligible Age

18 Years

Maximum Eligible Age

99 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amgen

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MD

Role: STUDY_DIRECTOR

Amgen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pinnacle Research Group LLC

Anniston, Alabama, United States

Site Status

Alliance For Multispecialty Research - Daphne

Daphne, Alabama, United States

Site Status

Alliance for Multispecialty Research Mobile

Mobile, Alabama, United States

Site Status

Avacare Foothills Research Center

Phoenix, Arizona, United States

Site Status

Ark Clinical Research- Tustin

Fountain Valley, California, United States

Site Status

Long Beach Clinical Trials Services Inc

Long Beach, California, United States

Site Status

Ark Clinical Research- Long Beach

Long Beach, California, United States

Site Status

Catalina Research Institute

Montclair, California, United States

Site Status

Artemis Institute for Clinical Research

Riverside, California, United States

Site Status

Artemis Institute for Clinical Research

San Diego, California, United States

Site Status

Apex Clinical Research

San Diego, California, United States

Site Status

Southern California Clinical Research

Santa Ana, California, United States

Site Status

Diablo Clinical Research

Walnut Creek, California, United States

Site Status

Yale School of Medicine

New Haven, Connecticut, United States

Site Status

Chase Medical Research LLC

Waterbury, Connecticut, United States

Site Status

Indago Research and Health Center

Hialeah, Florida, United States

Site Status

Jacksonville Center for Clinical Research

Jacksonville, Florida, United States

Site Status

Clinical Neuroscience Solutions - Jacksonville

Jacksonville, Florida, United States

Site Status

South Florida Wellness and Clinical Research Institute

Margate, Florida, United States

Site Status

Optimus U Corporation

Miami, Florida, United States

Site Status

Research Institute of South Florida

Miami, Florida, United States

Site Status

Renstar Medical Research

Ocala, Florida, United States

Site Status

Clinical Neuroscience Solutions - Orlando

Orlando, Florida, United States

Site Status

Combined Research Orlando Phase I IV

Orlando, Florida, United States

Site Status

Florida Institute for Clinical Research

Orlando, Florida, United States

Site Status

Encore Medical Research of Weston LLC

Weston, Florida, United States

Site Status

Center for Advanced Research and Education

Gainesville, Georgia, United States

Site Status

Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group

Union City, Georgia, United States

Site Status

East-West Medical Research

Honolulu, Hawaii, United States

Site Status

Solaris Clinical Research

Meridian, Idaho, United States

Site Status

Flourish Research - Great Lakes Clinical Trials

Chicago, Illinois, United States

Site Status

Endeavor Health Medical Group - Endocrinology and Diabetes- Skokie

Skokie, Illinois, United States

Site Status

Evanston Premier Healthcare Research LLC

Skokie, Illinois, United States

Site Status

Alliance for Multispecialty Research Newton

Newton, Kansas, United States

Site Status

Louisville Metabolic and Atherosclerosis Research Center

Louisville, Kentucky, United States

Site Status

Velocity Clinical Research - Baton Rouge

Baton Rouge, Louisiana, United States

Site Status

Tandem Clinical Research - Marrero

Marrero, Louisiana, United States

Site Status

Headlands Research - Detroit

Southfield, Michigan, United States

Site Status

Prime Health and Wellness Sky Clinical Research Network Group

Fayette, Mississippi, United States

Site Status

Alliance for Multispecialty Research - Kansas City

Kansas City, Missouri, United States

Site Status

Palm Research Center Inc

Las Vegas, Nevada, United States

Site Status

Vector Clinical Trials

Las Vegas, Nevada, United States

Site Status

Rochester Clinical Research

Rochester, New York, United States

Site Status

Velocity Clinical Research- Binghamton

Vestal, New York, United States

Site Status

Accellacare of Hickory

Hickory, North Carolina, United States

Site Status

Carolina Research Center Inc

Shelby, North Carolina, United States

Site Status

Wake Forest University Health Sciences

Winston-Salem, North Carolina, United States

Site Status

Clinical Trial Investigator Clinical Research Center

Cincinnati, Ohio, United States

Site Status

Velocity Clinical Research - Cincinnati

Cincinnati, Ohio, United States

Site Status

Alliance for Multispecialty Research - Norman

Norman, Oklahoma, United States

Site Status

Capital Area Research LLC

Newport, Pennsylvania, United States

Site Status

Velocity Clinical Research - Providence

East Greenwich, Rhode Island, United States

Site Status

Tribe Clinical Research LLC Dba Mountain View Clinical Research

Greenville, South Carolina, United States

Site Status

New Phase Research and Development

Knoxville, Tennessee, United States

Site Status

Accellacare US Inc., d/b/a Accellacare of Knoxville

Knoxville, Tennessee, United States

Site Status

Elligo Clinical Research Center

Austin, Texas, United States

Site Status

Cedar Health Research, LLC

Dallas, Texas, United States

Site Status

Epic Medical Research - Texas

DeSoto, Texas, United States

Site Status

Great Lakes Research Institute El Paso Research

El Paso, Texas, United States

Site Status

Cedar Health Research, LLC

Euless, Texas, United States

Site Status

Juno Research LLC

Houston, Texas, United States

Site Status

Biopharma Informatic, LLC

Houston, Texas, United States

Site Status

Juno Research LLC

Houston, Texas, United States

Site Status

Southern Endocrinology Associates PA

Mesquite, Texas, United States

Site Status

Great Lakes Research Institute - McAllen Research

Pharr, Texas, United States

Site Status

Clinical Trials of Texas

San Antonio, Texas, United States

Site Status

Sugar Lakes Family Practice

Sugar Land, Texas, United States

Site Status

Pantheon Clinical Research

Bountiful, Utah, United States

Site Status

Alliance for Multispecialty Research Layton Research Center

Layton, Utah, United States

Site Status

Chrysalis Clinical Research, LLC

St. George, Utah, United States

Site Status

Washington Center for Weight Management and Research, Inc

Arlington, Virginia, United States

Site Status

Health Research of Hampton Roads

Newport News, Virginia, United States

Site Status

Selma Medical Associates

Winchester, Virginia, United States

Site Status

Allegiance Research Specialists

Milwaukee, Wisconsin, United States

Site Status

Cedic - Centro de Investigacion Clinica

CABA, Buenos Aires, Argentina

Site Status

Centro Medico Viamonte

CABA, Buenos Aires, Argentina

Site Status

Cemedic Centro de Especialidades Medicas

CABA, Buenos Aires, Argentina

Site Status

Centro Medico Dra Laura Maffei Investigacion Clinica Aplicada

CABA, Buenos Aires, Argentina

Site Status

Consultorios Medicos Dr Besada

CABA, Buenos Aires, Argentina

Site Status

Fundacion Respirar

CABA, Buenos Aires, Argentina

Site Status

Cinme - Centro de Investigaciones Metabolicas

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Site Status

Ciprec - Centro de Investigacion y Prevencion Cardiovascular

Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

Site Status

Emeritus Research Sydney

Botany, New South Wales, Australia

Site Status

Novatrials

Charlestown, New South Wales, Australia

Site Status

Canopy Clinical Sutherland

Miranda, New South Wales, Australia

Site Status

Royal North Shore Hospital

St Leonards, New South Wales, Australia

Site Status

Canopy Clinical Wollongong

Wollongong, New South Wales, Australia

Site Status

Logan Hospital

Meadowbrook, Queensland, Australia

Site Status

Fusion Clinical Research

Norwood, South Australia, Australia

Site Status

Southern Adelaide Diabetes and Endocrine Services

Oaklands Park, South Australia, Australia

Site Status

Emeritus Research Camberwell

Camberwell, Victoria, Australia

Site Status

Austin Health, Heidelberg Repatriation Hospital

Heidelberg West, Victoria, Australia

Site Status

Canopy Clinical Altona North

North Altona, Victoria, Australia

Site Status

Universitair Ziekenhuis Antwerpen

Edegem, , Belgium

Site Status

Universitair Ziekenhuis Gent

Ghent, , Belgium

Site Status

Algemeen Ziekenhuis Groeninge - Campus Kennedylaan

Kortrijk, , Belgium

Site Status

Universitair Ziekenhuis Leuven - Campus Gasthuisberg

Leuven, , Belgium

Site Status

Centre Hospitalier Universitaire de Liege - Sart Tilman

Liège, , Belgium

Site Status

Algemeen Ziekenhuis Sint-Maarten

Mechelen, , Belgium

Site Status

Centres Hospitaliers Universitaires HELORA - Hôpital de Mons - Site Constantinople

Mons, , Belgium

Site Status

tlc Diabetes and Endocrinology

Surrey, British Columbia, Canada

Site Status

Wharton Medical Clinic

Hamilton, Ontario, Canada

Site Status

North York Diagnostic and Cardiac Centre

North York, Ontario, Canada

Site Status

Centricity Research Oshawa Multispecialty

Oshawa, Ontario, Canada

Site Status

Heart Health Institute Research Incorporated

Scarborough Village, Ontario, Canada

Site Status

Curans Heart Center

Thunder Bay, Ontario, Canada

Site Status

Centricity Research Toronto

Toronto, Ontario, Canada

Site Status

Diabetes Heart Research Centre

Toronto, Ontario, Canada

Site Status

Ecogene-21

Chicoutimi, Quebec, Canada

Site Status

Institut Universitaire de cardiologie et de pneumologie de Quebec

Québec, Quebec, Canada

Site Status

CardioVasc HR Incorporated

Saint-Jean-sur-Richelieu, Quebec, Canada

Site Status

Centre de Medecine Metabolique de Lanaudiere

Terrebonne, Quebec, Canada

Site Status

Medicus Services sro

Brandýs nad Labem, , Czechia

Site Status

Fakultni nemocnice Brno

Brno, , Czechia

Site Status

Endohope Havirov sro

Havířov, , Czechia

Site Status

PreventaMed sro

Olomouc, , Czechia

Site Status

CCR Ostrava sro

Ostrava, , Czechia

Site Status

Fakultni nemocnice Kralovske Vinohrady

Prague, , Czechia

Site Status

Vseobecna fakultni nemocnice v Praze

Prague, , Czechia

Site Status

Ob klinika as

Prague, , Czechia

Site Status

Institut klinicke a experimentalni mediciny

Prague, , Czechia

Site Status

Endohope klinika sro

Prague, , Czechia

Site Status

Endokrinologie Cerny Most sro

Prague, , Czechia

Site Status

Sanos Gandrup

Gandrup, , Denmark

Site Status

Gentofte Hospital

Hellerup, , Denmark

Site Status

Sanos Clinic

Herlev, , Denmark

Site Status

Steno Diabetes Center Copenhagen

Herlev, , Denmark

Site Status

Regionshospitalet Godstrup

Herning, , Denmark

Site Status

Hvidovre Hospital

Hvidovre, , Denmark

Site Status

Obesity Research Unit

Helsinki, , Finland

Site Status

Health Step Finland

Kuopio, , Finland

Site Status

Oulu University Hospital

Oulu, , Finland

Site Status

Universitaetsklinikum Aachen

Aachen, , Germany

Site Status

Kardiologische Praxis Dr med Wolfgang Jungmair

Bad Homburg, , Germany

Site Status

Universitaets-Herzzentrum Freiburg - Bad Krozingen

Bad Krozingen, , Germany

Site Status

Diabetespraxis Bad Mergentheim

Bad Mergentheim, , Germany

Site Status

Universitaetsklinikum der Ruhr-Universitaet Bochum

Bad Oeynhausen, , Germany

Site Status

Charite - Universitaetsmedizin Berlin, Campus Mitte

Berlin, , Germany

Site Status

Velocity Clinical Research GmbH

Berlin, , Germany

Site Status

Diabetespraxis Dr. Hermann Braun

Berlin, , Germany

Site Status

Mvz am Bahnhof Spandau

Berlin, , Germany

Site Status

Universitaetsklinikum Dresden

Dresden, , Germany

Site Status

Zentrum fuer Klinische Studien Suedbrandenburg GmbH

Elsterwerda, , Germany

Site Status

InnoDiab Forschung

Essen, , Germany

Site Status

Praxis am Markt Dr. Bernd Becker

Essen, , Germany

Site Status

Schwerpunktpraxis fuer Diabetes, Gefaess- & Ernaehrungsmedizin

Falkensee, , Germany

Site Status

ClinPhenomics CVC GmbH

Frankfurt am Main, , Germany

Site Status

Diabeteszentrum Hamburg West

Hamburg, , Germany

Site Status

Endokrinologikum Hamburg

Hamburg, , Germany

Site Status

Diabetologische Schwerpunktpraxis Hohenmoelsen

Hohenmölsen, , Germany

Site Status

Braun Ambulantes Herzzentrum Kassel

Kassel, , Germany

Site Status

Universitaetsklinikum Leipzig

Leipzig, , Germany

Site Status

AmBeNet GmbH

Leipzig, , Germany

Site Status

Universitaetsklinikum Schleswig-Holstein - Luebeck

Lübeck, , Germany

Site Status

Marienhaus Klinikum Mainz

Mainz, , Germany

Site Status

Kardiologische Praxis Doktor Jens Taggeselle

Markkleeberg, , Germany

Site Status

Centrum für Diagnostik und Gesundheit

München, , Germany

Site Status

Zentrum fuer Diabtes und Gefaesskrankheiten im Franziskus Carré Muenster

Münster, , Germany

Site Status

Praxis Segner - Dr. Braun - Kirsch

Oberwürzbach, , Germany

Site Status

Red-Institut GmbH

Oldenburg, , Germany

Site Status

Gemeinschaftspraxis Prof Jacob/ Dr Jacob

Villingen-Schwenningen, , Germany

Site Status

Zentrum fuer klinische Forschung Allgaeu Oberschwaben

Wangen, , Germany

Site Status

IRCCS Azienda Ospedaliero Universitaria di Bologna Policlinico di Sant Orsola

Bologna, , Italy

Site Status

Universita degli Studi Gabriele D Annunzio di Chieti e Pescara

Chieti, , Italy

Site Status

Azienda Ospedaliero Universitaria Careggi

Florence, , Italy

Site Status

IRCCS Centro Cardiologico Monzino

Milan, , Italy

Site Status

Azienda Socio Sanitaria Territoriale Fatebenefratelli Sacco

Milan, , Italy

Site Status

Ospedale Civico, Di Cristina e Benfratelli

Palermo, , Italy

Site Status

Azienda Ospedaliero Universitaria Pisana

Pisa, , Italy

Site Status

Fondazione Policlinico Tor Vergata

Roma, , Italy

Site Status

Medical Corporation Hitomikai Motomachi Takatsuka Naika Clinic

Yokohama, Kanagawa, Japan

Site Status

Doujin Memorial Foundation, Meiwa Hospital

Chiyoda-ku, Tokyo, Japan

Site Status

Tokyo Asbo Clinic

Chuo-ku, Tokyo, Japan

Site Status

Medical Corp Seikoukai New Medical Research System Clinic

Hachioji-shi, Tokyo, Japan

Site Status

Medical Corporation AOT Shinagawa Strings Clinic

Minato-ku, Tokyo, Japan

Site Status

Clinical Research Hospital Tokyo

Shinjuku-ku, Tokyo, Japan

Site Status

Medical Corporation Hanabusakai Shinei Medical Healthcare Clinic

Suginami-ku, Tokyo, Japan

Site Status

Gabinet Leczenia Otylosci i Chorob Dietozaleznych dr hab n med Lucyna Ostrowska

Bialystok, , Poland

Site Status

Kresmed Spolka z Ograniczona Odpowiedzialnoscia

Bialystok, , Poland

Site Status

Etg Lublin Spzoo

Dębica, , Poland

Site Status

Futuremeds Spolka z ograniczona odpowiedzialnoscia

Gdynia, , Poland

Site Status

Uniwersyteckie Centrum Kliniczne im Prof K Gibinskiego Slaskiego UM w Katowicach

Katowice, , Poland

Site Status

Salvia-Lekston i Madej Spolka Jawna

Katowice, , Poland

Site Status

Centrum Terapii Wspolczesnej J M Jasnorzewska Spolka Komandytowo Akcyjna

Lodz, , Poland

Site Status

Ekamed Spolka z Ograniczona Odpowiedzialnoscia

Lublin, , Poland

Site Status

Centrum Zdrowia Metabolicznego Pawel Bogdanski

Poznan, , Poland

Site Status

Clinical Research Center Spzoo Medic-R Spolka Komandytowa

Poznan, , Poland

Site Status

Futuremeds Spolka z ograniczona odpowiedzialnoscia

Warsaw, , Poland

Site Status

Clinical Best Solutions Sp zoo Spolka komandytowa

Warsaw, , Poland

Site Status

Ponce Medical School Foundation Inc

Ponce, , Puerto Rico

Site Status

Puerto Rico Medical Research Inc.

Ponce, , Puerto Rico

Site Status

Latin Clinical Trial Center

San Juan, , Puerto Rico

Site Status

Wellness Clinical Research Vega Baja

Vega Baja, , Puerto Rico

Site Status

Korea University Ansan Hospital

Ansan-si, Gyeonggi-do, , South Korea

Site Status

Hallym University Sacred Heart Hospital

Anyang-si, Gyeonggi-do, , South Korea

Site Status

The Catholic University of Korea Bucheon St Marys Hospital

Bucheon, Gyeonggi-do, , South Korea

Site Status

Dong-A University Hospital

Busan, , South Korea

Site Status

Kyungpook National University Hospital

Daegu, , South Korea

Site Status

Yeungnam University Medical Center

Daegu, , South Korea

Site Status

Daejeon Eulji Medical Center, Eulji University

Daejeon, , South Korea

Site Status

Konyang University Hospital

Daejeon, , South Korea

Site Status

Dongguk University Ilsan Hospital

Goyang-si, Gyeonggi-do, , South Korea

Site Status

Gachon University Gil Medical Center

Incheon, , South Korea

Site Status

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, , South Korea

Site Status

Seoul National University Hospital

Seoul, , South Korea

Site Status

Kangbuk Samsung Hospital

Seoul, , South Korea

Site Status

Severance Hospital Yonsei University Health System

Seoul, , South Korea

Site Status

KyungHee University Gangdong Hospital

Seoul, , South Korea

Site Status

Seoul Metropolitan Government Seoul National University Boramae Medical Center

Seoul, , South Korea

Site Status

The Catholic University of Korea Yeouido St Marys Hospital

Seoul, , South Korea

Site Status

Ajou University Hospital

Suwon-si Gyeonggi-do, , South Korea

Site Status

Pusan National University Yangsan Hospital

Yangsan-si, Gyeongsangnam-do, , South Korea

Site Status

Centro Periferico de Especialidades Bola Azul

Almería, Andalusia, Spain

Site Status

Hospital Vithas Sevilla

Castilleja de la Cuesta, Andalusia, Spain

Site Status

Hospital Infanta Elena

Huelva, Andalusia, Spain

Site Status

Hospital Virgen del Camino

Sanlúcar de Barrameda, Andalusia, Spain

Site Status

Nuevas Tecnologias en Diabetes y Endocrinologia

Seville, Andalusia, Spain

Site Status

Hospital Quironsalud Infanta Luisa

Seville, Andalusia, Spain

Site Status

Hospital Medico Quirurgico San Rafael

A Coruña, Galicia, Spain

Site Status

Clinica Ruber SA

Pozuelo de Alarcón, Madrid, Spain

Site Status

Clinica Universidad de Navarra

Pamplona, Navarre, Spain

Site Status

Clinica Juaneda

Palma, , Spain

Site Status

Hospital Universitario Doctor Peset

Valencia, , Spain

Site Status

Universitaetsspital Basel

Basel, , Switzerland

Site Status

Hopitaux Universitaires de Geneve

Geneva, , Switzerland

Site Status

Kantonsspital Sankt Gallen

Sankt Gallen, , Switzerland

Site Status

Stoffwechselzentrum Sankt Gallen

Sankt Gallen, , Switzerland

Site Status

Universitaetsspital Zuerich

Zurich, , Switzerland

Site Status

Ormeau Clinical Trials Ltd

Belfast, , United Kingdom

Site Status

FutureMeds Birmingham

Birmingham, , United Kingdom

Site Status

Layton Medical Centre

Blackpool, , United Kingdom

Site Status

Waterloo Medical Centre

Blackpool, , United Kingdom

Site Status

Southmead Hospital

Bristol, , United Kingdom

Site Status

The Rame Group Practice

Cornwall, , United Kingdom

Site Status

Staploe Medical Centre

Ely, , United Kingdom

Site Status

FutureMeds Glasgow

Glasgow, , United Kingdom

Site Status

Hull Royal Infirmary

Hull, , United Kingdom

Site Status

NIHR Leicestershire & Northamptonshire Commercial Research Delivery Centre

Leicester, , United Kingdom

Site Status

Aintree University Hospital

Liverpool, , United Kingdom

Site Status

FutureMeds Newcastle

Newcastle upon Tyne, , United Kingdom

Site Status

Atlantic Medical Group

Penzance, , United Kingdom

Site Status

Clifton Medical Centre

Rotherham, , United Kingdom

Site Status

Ashfields Primary Care Centre

Sandbach, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Belgium Canada Czechia Denmark Finland Germany Italy Japan Poland Puerto Rico South Korea Spain Switzerland United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

http://www.amgentrials.com

AmgenTrials clinical trials website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-515524-36

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

20210181

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Obese Patients With Type 2 Diabetes
NCT00029848 COMPLETED PHASE3